Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome

Chih Liang Wang, Chun I. Wang, Pao-Chi Liao, Chi De Chen, Ying Liang, Wen Yu Chuang, Ying Huang Tsai, Hua Chien Chen, Yu Sun Chang, Jau Song Yu, Chih Ching Wu, Chia Jung Yu

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, which is one of the most prominent causes of cancer-related mortality worldwide. Discovery of serum tumor markers could facilitate early NSCLC detection and metastatic prognosis. Here, we simultaneously analyzed the NSCLC cell secretome and proteomic profiles of pleural effusion from lung adenocarcinoma patients for NSCLC biomarker discovery. Retinoblastoma-associated binding protein 46 (RbAp46), one of the proteins detected both in NSCLC cell secretome and pleural effusion proteome, was chosen for further evaluation. Both of RbAp46 mRNA and protein levels were upregulated significantly in NSCLC cancer tissues. Serum levels of RbAp46 were markedly higher in NSCLC patients than in healthy controls, and a combination of RbAp46 and CEA could outperform CEA alone in discriminating NSCLC patients from healthy persons. Importantly, elevated serum RbAp46 level was highly correlated with NSCLC distant metastasis. Moreover, knockdown of RbAp46 inhibited the migration ability of lung cancer cells. Our data collectively suggest that RbAp46 serves as a novel biomarker and prognosticator for NSCLC, and is involved in lung cancer cell migration.

Original languageEnglish
Pages (from-to)4428-4440
Number of pages13
JournalJournal of Proteome Research
Volume8
Issue number10
DOIs
Publication statusPublished - 2009 Oct 19

Fingerprint

Retinoblastoma-Binding Protein 7
Retinoblastoma Binding Proteins
Pleural Effusion
Proteome
Non-Small Cell Lung Carcinoma
Carrier Proteins
Cells
Neoplasm Metastasis
Neoplasms
Tumor Biomarkers
Lung Neoplasms
Biomarkers
Proteins

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Chemistry(all)

Cite this

Wang, Chih Liang ; Wang, Chun I. ; Liao, Pao-Chi ; Chen, Chi De ; Liang, Ying ; Chuang, Wen Yu ; Tsai, Ying Huang ; Chen, Hua Chien ; Chang, Yu Sun ; Yu, Jau Song ; Wu, Chih Ching ; Yu, Chia Jung. / Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. In: Journal of Proteome Research. 2009 ; Vol. 8, No. 10. pp. 4428-4440.
@article{9724995abc324df2a132d806fa7a1dc3,
title = "Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome",
abstract = "Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, which is one of the most prominent causes of cancer-related mortality worldwide. Discovery of serum tumor markers could facilitate early NSCLC detection and metastatic prognosis. Here, we simultaneously analyzed the NSCLC cell secretome and proteomic profiles of pleural effusion from lung adenocarcinoma patients for NSCLC biomarker discovery. Retinoblastoma-associated binding protein 46 (RbAp46), one of the proteins detected both in NSCLC cell secretome and pleural effusion proteome, was chosen for further evaluation. Both of RbAp46 mRNA and protein levels were upregulated significantly in NSCLC cancer tissues. Serum levels of RbAp46 were markedly higher in NSCLC patients than in healthy controls, and a combination of RbAp46 and CEA could outperform CEA alone in discriminating NSCLC patients from healthy persons. Importantly, elevated serum RbAp46 level was highly correlated with NSCLC distant metastasis. Moreover, knockdown of RbAp46 inhibited the migration ability of lung cancer cells. Our data collectively suggest that RbAp46 serves as a novel biomarker and prognosticator for NSCLC, and is involved in lung cancer cell migration.",
author = "Wang, {Chih Liang} and Wang, {Chun I.} and Pao-Chi Liao and Chen, {Chi De} and Ying Liang and Chuang, {Wen Yu} and Tsai, {Ying Huang} and Chen, {Hua Chien} and Chang, {Yu Sun} and Yu, {Jau Song} and Wu, {Chih Ching} and Yu, {Chia Jung}",
year = "2009",
month = "10",
day = "19",
doi = "10.1021/pr900160h",
language = "English",
volume = "8",
pages = "4428--4440",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "10",

}

Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. / Wang, Chih Liang; Wang, Chun I.; Liao, Pao-Chi; Chen, Chi De; Liang, Ying; Chuang, Wen Yu; Tsai, Ying Huang; Chen, Hua Chien; Chang, Yu Sun; Yu, Jau Song; Wu, Chih Ching; Yu, Chia Jung.

In: Journal of Proteome Research, Vol. 8, No. 10, 19.10.2009, p. 4428-4440.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome

AU - Wang, Chih Liang

AU - Wang, Chun I.

AU - Liao, Pao-Chi

AU - Chen, Chi De

AU - Liang, Ying

AU - Chuang, Wen Yu

AU - Tsai, Ying Huang

AU - Chen, Hua Chien

AU - Chang, Yu Sun

AU - Yu, Jau Song

AU - Wu, Chih Ching

AU - Yu, Chia Jung

PY - 2009/10/19

Y1 - 2009/10/19

N2 - Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, which is one of the most prominent causes of cancer-related mortality worldwide. Discovery of serum tumor markers could facilitate early NSCLC detection and metastatic prognosis. Here, we simultaneously analyzed the NSCLC cell secretome and proteomic profiles of pleural effusion from lung adenocarcinoma patients for NSCLC biomarker discovery. Retinoblastoma-associated binding protein 46 (RbAp46), one of the proteins detected both in NSCLC cell secretome and pleural effusion proteome, was chosen for further evaluation. Both of RbAp46 mRNA and protein levels were upregulated significantly in NSCLC cancer tissues. Serum levels of RbAp46 were markedly higher in NSCLC patients than in healthy controls, and a combination of RbAp46 and CEA could outperform CEA alone in discriminating NSCLC patients from healthy persons. Importantly, elevated serum RbAp46 level was highly correlated with NSCLC distant metastasis. Moreover, knockdown of RbAp46 inhibited the migration ability of lung cancer cells. Our data collectively suggest that RbAp46 serves as a novel biomarker and prognosticator for NSCLC, and is involved in lung cancer cell migration.

AB - Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer, which is one of the most prominent causes of cancer-related mortality worldwide. Discovery of serum tumor markers could facilitate early NSCLC detection and metastatic prognosis. Here, we simultaneously analyzed the NSCLC cell secretome and proteomic profiles of pleural effusion from lung adenocarcinoma patients for NSCLC biomarker discovery. Retinoblastoma-associated binding protein 46 (RbAp46), one of the proteins detected both in NSCLC cell secretome and pleural effusion proteome, was chosen for further evaluation. Both of RbAp46 mRNA and protein levels were upregulated significantly in NSCLC cancer tissues. Serum levels of RbAp46 were markedly higher in NSCLC patients than in healthy controls, and a combination of RbAp46 and CEA could outperform CEA alone in discriminating NSCLC patients from healthy persons. Importantly, elevated serum RbAp46 level was highly correlated with NSCLC distant metastasis. Moreover, knockdown of RbAp46 inhibited the migration ability of lung cancer cells. Our data collectively suggest that RbAp46 serves as a novel biomarker and prognosticator for NSCLC, and is involved in lung cancer cell migration.

UR - http://www.scopus.com/inward/record.url?scp=70349972788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349972788&partnerID=8YFLogxK

U2 - 10.1021/pr900160h

DO - 10.1021/pr900160h

M3 - Article

VL - 8

SP - 4428

EP - 4440

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 10

ER -